Karin Kurnik
- Hematology top 0.5%
- Internal Medicine top 1%
- Genetics top 2%
- Epidemiology top 10%
- Surgery top 10%
- Co-authors
- Ulrike Nowak‐GöttlR. SchobeßRonald SträterRalf JunkerChristine HellerAndrea KoschGudrun GüntherW. Kreuz
- Topics
- Hemophilia Treatment and Research (43 papers)Blood Coagulation and Thrombosis Mechanisms (39 papers)Platelet Disorders and Treatments (25 papers)
- Cited by
- HematologyInternal MedicineGenetics
- Journals
- The LancetBloodPLoS ONE
- Partner nations
- GermanyUnited KingdomIsrael
In The Last Decade
Karin Kurnik
79 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 86
- Hematology 2.0k
- Internal Medicine 434
- Genetics 406
- Epidemiology 364
- Surgery 335
Countries citing papers authored by Karin Kurnik
This map shows the geographic impact of Karin Kurnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Kurnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Kurnik more than expected).
Fields of papers citing papers by Karin Kurnik
This network shows the impact of papers produced by Karin Kurnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Kurnik. The network helps show where Karin Kurnik may publish in the future.
Co-authorship network of co-authors of Karin Kurnik
This figure shows the co-authorship network connecting the top 25 collaborators of Karin Kurnik. A scholar is included among the top collaborators of Karin Kurnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Kurnik. Karin Kurnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Real World Prospective Data on Bleeding Frequency in 1,000 Patients with Hemophilia a - is the Goal of Zero Bleeds Achievable? | 4 |
| 2 | 8 | |
| 3 | 8 | |
| 4 | 12 | |
| 5 | 27 | |
| 6 | 1 | |
| 7 | 24 | |
| 8 | 10 | |
| 9 | 12 | |
| 10 | 62 | |
| 11 | 8 | |
| 12 | 4 | |
| 13 | 16 | |
| 14 | 39 | |
| 15 | 46 | |
| 16 | 84 | |
| 17 | 19 | |
| 18 | 32 | |
| 19 | 83 | |
| 20 | Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: A family study | 2 |
About Karin Kurnik
Karin Kurnik is a scholar working on Hematology, Internal Medicine and Genetics, having authored 83 papers that have together received 2.5k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (43 papers), Blood Coagulation and Thrombosis Mechanisms (39 papers) and Platelet Disorders and Treatments (25 papers). The work is most often cited by research in Hematology (2.0k citations), Internal Medicine (434 citations) and Genetics (406 citations). Karin Kurnik has collaborated with scholars based in Germany, United Kingdom and Israel. Frequent co-authors include Ulrike Nowak‐Göttl, R. Schobeß, Ronald Sträter, Ralf Junker, Christine Heller, Andrea Kosch, Gudrun Günther, W. Kreuz, Achim Heinecke and Arnold von Eckardstein. Their work appears in journals such as The Lancet, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.